Stocks and Investing
Stocks and Investing
Wed, August 16, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, August 15, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Gregory Renza Reiterated (VIRX) at Buy and Held Target at $7 on, Aug 15th, 2023
Gregory Renza of RBC Capital, Reiterated "Viracta Therapeutics, Inc." (VIRX) at Buy and Held Target at $7 on, Aug 15th, 2023.
Gregory has made no other calls on VIRX in the last 4 months.
There is 1 other peer that has a rating on VIRX. Out of the 1 peers that are also analyzing VIRX, 0 agree with Gregory's Rating of Hold.
This is the rating of the analyst that currently disagrees with Gregory
- Tony Butler of "EF Hutton" Initiated at Strong Buy and Held Target at $10 on, Monday, July 31st, 2023
Contributing Sources